Category:
Description:
Indications:
-
Menopausal
vasomotor symptoms (hot flashes, etc.)
-
Female
hypogonadism
-
Female
castration and primary ovarian failure
-
Atrophic
conditions caused by deficient estrogen production
Contraindications:
-
Known
or suspected breast cancer
-
Known
or suspected estrogen-dependent neoplasia
-
Known
or suspected pregnancy
-
Undiagnosed
genital bleeding
-
Current
or history of thrombophlebitis, thrombosis, thromboembolic disorders
(except when used in breast or prostatic cancer treatment).
Precautions:
-
Pregnancy
category X
-
Use
with caution in patients with hypertension, diabetes, epilepsy,
cardiac, liver or renal dysfunction, history of depression, gall
bladder disease, hepatic adenoma.
-
Use
with caution in nursing mothers.
-
Use
with extreme caution in women with a family history of breast cancer
or who have breast nodules.
-
Perform
periodic breast examinations.
-
Rotate
patch application sites to decrease skin sensitivity.
-
May
decrease glucose intolerance in diabetic patients.
-
Discontinue
therapy and contact health care provider if pregnancy is suspected.
Adverse
Reactions (Side Effects):
|
Dosage:
-
Administered
orally or transdermal patch
-
1-2gm
per day, attempting to achieve lowest possible dose
-
10-20cm2
per patch applied twice weekly, rotating sites (avoid breasts and
waistline)
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks. Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
|